Firms

PAACS Invest

PAACS Invest is a privately owned Norwegian investment company and family office focused on active investments in healthcare and technology, with an emphasis on sustainability and precision health. It supports early-stage life-sciences companies with capital and company-development advice. Issuer materials identify investments in Hemispherian, EXACT Therapeutics, PubGene and RemovAid. The Norwegian legal company is PAACS Invest AS.

Founded: 2007
Type: Venture capital

Funds0

No funds on record yet.

Team

Operations and support

Dag StrømmeBoard Chair

Ewal Martin StrømmeDeputy Board Member

Masha StrømmeInvestor and Co-chair (self-described April 2023; current tenure unconfirmed)

Co-investing

Investinor

Hemispherian$— · 2021-01-27

Investments

$—2021-01-27

Hemispherian

Investinor, PAACS Invest

team@apexlogos.ai19 hours ago
PAACS Invest AS is registered 990735441, incorporated January 2, 2007. Current registry identifies Dag Wilhelm Ringvold Strømme as chair and Ewal Martin Strømme as deputy, both avregistrert=false. Masha Strømme’s investor/co-chair title is self-described April 26, 2023 and is not the legally registered chair title; current tenure not independently reaffirmed. No verified own website or authentic published firm logo was found, and unrelated PAACS surgical-charity branding must not be substituted. Sources: https://data.brreg.no/enhetsregisteret/api/enheter/990735441 ; https://data.brreg.no/enhetsregisteret/api/enheter/990735441/roller ; https://www.dehns.com/insights/celebrating-world-intellectual-property-day-2023-an-interview-with-masha-stromme/ . No new external fund closing within October 6, 2023–October 7, 2026 proved.